Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer. (1st August 2018)

• Record Type: Journal Article
• Authors: Jian, Yunting; Wang, Meng; Zhang, Yan; Ou, Ruizhang; Zhu, Ziyuan; Ou, Yangying; Chen, Xiangfu; Liang, Xin; Ding, Yanqing; Song, Libing; Xu, Xuehu; Liao, Wenting
• Is Part Of: Cancer letters. Volume 428(2018)
• Page Start: 1
• Page End: 11
• Publication Date: 2018-08-01
• Subjects: JADE3 -- Colon cancer -- Cancer stem cells -- Tumorigenesis -- LGR5; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2018.04.012
• Languages: English
• ISSNs: 0304-3835

Abstract

Abstract: Jade family PHD finger 3 (JADE3) plays a role in inducing histone acetylation during transcription, and is involved in the progression of several human cancers; however, its role in colon cancer remains unclear. Herein, we found that JADE3 was markedly upregulated in colon cancer tissues and significantly correlated with cancer progression, and predicted shorter patient survival. Further, JADE3 was expressed much higher in colon cancer cell lines that are enriched with a stem-like signature. Overexpression of JADE3 increased, while silencing JADE3 reduced cancer stem cell-like traits in colon cancer cells in vitro and in vivo . Importantly, silencing of JADE3 strongly impaired the tumor initiating capacity of colon cancer cells in vivo . Furthermore, JADE3 interacted with the promoters of colon stem cell marker LGR5 and activated its transcription, by increasing the occupancy of p300 acetyltransferase and histone acetylation on the promoters. Finally, we found that JADE3 expression was substantially induced by Wnt/β-catenin signaling. These findings suggest an oncogenic role of JADE3 by regulating cancer stem cell-like traits in the colon cancer, and therefore JADE3 might be a potential therapeutic target for the treatment of colon cancer. Highlights: JADE3 correlated with colon cancer progression and predicted poor patient survival. JADE3 enhanced self-renewal capacity and tumorigenicity in colon cancer. JADE3 interacted with the promoters of LGR5 and enhanced its transcriptional activity. Ectopic expression of JADE3 was induced by the Wnt/β-catenin signaling.